Efficacy and Safety Study of Polyphenon E to Treat External Genital WartsEndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsStudy Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy VolunteersStudy Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet FormulationPharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea BeverageA Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic MetastasesEndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the PancreasPhase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®G207 Followed by Radiation Therapy in Malignant GliomaSafety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the LiverSafety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer
P859
Q61921116-5FF40532-FCB7-4BBB-B270-1970CEECA4F7Q61923824-C9309024-D09F-40DC-9E05-BF3FE2669A81Q61957752-9F56A3FF-6F7A-48F2-B0D9-59CDC1D1C0F6Q63320934-4BE1DC83-DD03-4097-9092-ECBFD21D0158Q64042173-32EB6315-B00E-4AF3-836B-44657B72CE34Q64655903-F81437A2-FD54-4B82-B498-FA195567305FQ65380077-47492805-75FB-41CA-A776-92F75D083EDDQ65388651-95C95582-5EF7-44A2-8722-385C0EFA082EQ65472383-A536322C-2637-46F4-8276-AFB0873883D5Q66027978-E9E65699-315B-436A-9170-70BAD42B5584Q66028887-50CE3E87-EC09-49AF-AA7E-A1A46CC49047Q66039482-BA70AA38-DC44-4632-B67C-89EE9877AD91
P859
description
bedrijf uit Duitsland
@nl
company
@en
name
MediGene
@de
MediGene
@en
MediGene
@fr
MediGene
@nl
type
label
MediGene
@de
MediGene
@en
MediGene
@fr
MediGene
@nl
prefLabel
MediGene
@de
MediGene
@en
MediGene
@fr
MediGene
@nl
P361
P6366
P646
P1037
P1454
P159
P213
0000 0004 0554 3944
P2427
grid.487265.a
P31
P3500
P452
P571
1994-01-01T00:00:00Z
P6366
P646
/m/05p42gp
P6782
P946
DE000A1X3W00